nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—CYP3A4—bone cancer	0.921	1	CbGaD
Bromazepam—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.00473	0.0695	CbGpPWpGaD
Bromazepam—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00284	0.0418	CbGpPWpGaD
Bromazepam—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00155	0.0228	CbGpPWpGaD
Bromazepam—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0012	0.0176	CbGpPWpGaD
Bromazepam—GABRQ—Orphan transporters—TUBB4B—bone cancer	0.00114	0.0167	CbGpPWpGaD
Bromazepam—GABRR2—Mecp2 and Associated Rett Syndrome—EZH2—bone cancer	0.00111	0.0163	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—FEV—bone cancer	0.0011	0.0162	CbGpPWpGaD
Bromazepam—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.00104	0.0153	CbGpPWpGaD
Bromazepam—GABRQ—Orphan transporters—TUBB2A—bone cancer	0.000985	0.0145	CbGpPWpGaD
Bromazepam—Clonazepam—CYP3A4—bone cancer	0.000956	0.261	CrCbGaD
Bromazepam—GABRG3—Orphan transporters—TUBB4B—bone cancer	0.000939	0.0138	CbGpPWpGaD
Bromazepam—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000934	0.0137	CbGpPWpGaD
Bromazepam—Clorazepate—CYP3A4—bone cancer	0.000926	0.253	CrCbGaD
Bromazepam—GABRB1—Orphan transporters—TUBB4B—bone cancer	0.000925	0.0136	CbGpPWpGaD
Bromazepam—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000896	0.0132	CbGpPWpGaD
Bromazepam—GABRA6—Orphan transporters—TUBB4B—bone cancer	0.000875	0.0129	CbGpPWpGaD
Bromazepam—GABRA4—Orphan transporters—TUBB4B—bone cancer	0.000864	0.0127	CbGpPWpGaD
Bromazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000839	0.0123	CbGpPWpGaD
Bromazepam—GABRG3—Orphan transporters—TUBB2A—bone cancer	0.000811	0.0119	CbGpPWpGaD
Bromazepam—GABRB1—Orphan transporters—TUBB2A—bone cancer	0.000799	0.0117	CbGpPWpGaD
Bromazepam—GABRB2—Orphan transporters—TUBB4B—bone cancer	0.000791	0.0116	CbGpPWpGaD
Bromazepam—GABRA5—Orphan transporters—TUBB4B—bone cancer	0.000768	0.0113	CbGpPWpGaD
Bromazepam—GABRA6—Orphan transporters—TUBB2A—bone cancer	0.000756	0.0111	CbGpPWpGaD
Bromazepam—GABRA3—Orphan transporters—TUBB4B—bone cancer	0.000754	0.0111	CbGpPWpGaD
Bromazepam—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00075	0.011	CbGpPWpGaD
Bromazepam—GABRA4—Orphan transporters—TUBB2A—bone cancer	0.000746	0.011	CbGpPWpGaD
Bromazepam—GABRA2—Orphan transporters—TUBB4B—bone cancer	0.000741	0.0109	CbGpPWpGaD
Bromazepam—GABRB3—Orphan transporters—TUBB4B—bone cancer	0.000736	0.0108	CbGpPWpGaD
Bromazepam—GABRG2—Orphan transporters—TUBB4B—bone cancer	0.000723	0.0106	CbGpPWpGaD
Bromazepam—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000721	0.0106	CbGpPWpGaD
Bromazepam—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000721	0.0106	CbGpPWpGaD
Bromazepam—Nitrazepam—CYP3A4—bone cancer	0.000693	0.189	CrCbGaD
Bromazepam—GABRB2—Orphan transporters—TUBB2A—bone cancer	0.000682	0.01	CbGpPWpGaD
Bromazepam—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000678	0.00996	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000669	0.00982	CbGpPWpGaD
Bromazepam—GABRA5—Orphan transporters—TUBB2A—bone cancer	0.000663	0.00973	CbGpPWpGaD
Bromazepam—GABRA3—Orphan transporters—TUBB2A—bone cancer	0.000651	0.00956	CbGpPWpGaD
Bromazepam—GABRA2—Orphan transporters—TUBB2A—bone cancer	0.00064	0.00939	CbGpPWpGaD
Bromazepam—GABRB3—Orphan transporters—TUBB2A—bone cancer	0.000636	0.00933	CbGpPWpGaD
Bromazepam—GABRA1—Orphan transporters—TUBB4B—bone cancer	0.000632	0.00928	CbGpPWpGaD
Bromazepam—GABRG2—Orphan transporters—TUBB2A—bone cancer	0.000624	0.00916	CbGpPWpGaD
Bromazepam—Oxazepam—CYP3A4—bone cancer	0.000596	0.163	CrCbGaD
Bromazepam—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000578	0.00849	CbGpPWpGaD
Bromazepam—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000556	0.00817	CbGpPWpGaD
Bromazepam—GABRA1—Orphan transporters—TUBB2A—bone cancer	0.000546	0.00801	CbGpPWpGaD
Bromazepam—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000539	0.00791	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000516	0.00757	CbGpPWpGaD
Bromazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000505	0.00741	CbGpPWpGaD
Bromazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00049	0.0072	CbGpPWpGaD
Bromazepam—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.00049	0.0072	CbGpPWpGaD
Bromazepam—Diazepam—CYP3A4—bone cancer	0.000489	0.134	CrCbGaD
Bromazepam—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.00047	0.00689	CbGpPWpGaD
Bromazepam—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000451	0.00662	CbGpPWpGaD
Bromazepam—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000433	0.00636	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000402	0.0059	CbGpPWpGaD
Bromazepam—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000397	0.00583	CbGpPWpGaD
Bromazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000389	0.00572	CbGpPWpGaD
Bromazepam—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000385	0.00565	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—EIF2S1—bone cancer	0.000342	0.00502	CbGpPWpGaD
Bromazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000311	0.00457	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.00031	0.00455	CbGpPWpGaD
Bromazepam—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000307	0.00451	CbGpPWpGaD
Bromazepam—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000295	0.00433	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000292	0.00429	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000278	0.00409	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000278	0.00409	CbGpPWpGaD
Bromazepam—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.000254	0.00373	CbGpPWpGaD
Bromazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000252	0.00371	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000252	0.0037	CbGpPWpGaD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000246	0.00362	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00024	0.00353	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00024	0.00353	CbGpPWpGaD
Bromazepam—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00024	0.00353	CbGpPWpGaD
Bromazepam—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000237	0.00348	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000235	0.00345	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000235	0.00345	CbGpPWpGaD
Bromazepam—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000231	0.0034	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000229	0.00337	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000226	0.00332	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000214	0.00314	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000211	0.0031	CbGpPWpGaD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000206	0.00303	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000198	0.00291	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000197	0.00289	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000197	0.00289	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000195	0.00286	CbGpPWpGaD
Bromazepam—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000195	0.00286	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000193	0.00284	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000193	0.00283	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000191	0.0028	CbGpPWpGaD
Bromazepam—Multiple fractures—Methotrexate—bone cancer	0.000188	0.0276	CcSEcCtD
Bromazepam—Fracture—Methotrexate—bone cancer	0.000188	0.0276	CcSEcCtD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000188	0.00275	CbGpPWpGaD
Bromazepam—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000187	0.00275	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000185	0.00272	CbGpPWpGaD
Bromazepam—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000185	0.00271	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000184	0.00271	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000184	0.0027	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000182	0.00267	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000181	0.00266	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00018	0.00265	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00018	0.00264	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000178	0.00261	CbGpPWpGaD
Bromazepam—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000177	0.0026	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000177	0.00259	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—BRAF—bone cancer	0.000177	0.00259	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000177	0.00259	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000167	0.00245	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000163	0.00239	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000162	0.00238	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000162	0.00238	CbGpPWpGaD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00016	0.00234	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000159	0.00233	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000158	0.00232	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000156	0.00229	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000155	0.00228	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000155	0.00228	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000155	0.00228	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000154	0.00227	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000153	0.00224	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000152	0.00224	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000152	0.00223	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000152	0.00223	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000151	0.00222	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000149	0.00219	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.000149	0.00219	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—MDM2—bone cancer	0.000148	0.00217	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000148	0.00217	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000145	0.00214	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—BRAF—bone cancer	0.000143	0.0021	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—BRAF—bone cancer	0.000142	0.00208	CbGpPWpGaD
Bromazepam—Irritability—Cisplatin—bone cancer	0.000138	0.0203	CcSEcCtD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000136	0.002	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—BRAF—bone cancer	0.000136	0.00199	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—BRAF—bone cancer	0.000135	0.00199	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—BRAF—bone cancer	0.000135	0.00199	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000134	0.00197	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—BRAF—bone cancer	0.000134	0.00197	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000133	0.00196	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000133	0.00195	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000132	0.00194	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.00013	0.00191	CbGpPWpGaD
Bromazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00013	0.00191	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000128	0.00188	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000127	0.00187	CbGpPWpGaD
Bromazepam—Speech disorder—Methotrexate—bone cancer	0.000127	0.0187	CcSEcCtD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000125	0.00183	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000125	0.00183	CbGpPWpGaD
Bromazepam—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000123	0.00181	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000122	0.0018	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000122	0.00179	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—MDM2—bone cancer	0.00012	0.00176	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—BRAF—bone cancer	0.000119	0.00175	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—MDM2—bone cancer	0.000119	0.00174	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—GSTP1—bone cancer	0.000118	0.00173	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000117	0.00171	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000115	0.00168	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—GSTP1—bone cancer	0.000115	0.00168	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000114	0.00167	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—MDM2—bone cancer	0.000114	0.00167	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—MDM2—bone cancer	0.000113	0.00166	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—MDM2—bone cancer	0.000113	0.00166	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	0.000113	0.00166	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—MDM2—bone cancer	0.000112	0.00165	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—BRAF—bone cancer	0.000112	0.00164	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—BRAF—bone cancer	0.000111	0.00164	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—BRAF—bone cancer	0.00011	0.00161	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.000109	0.0016	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—JUN—bone cancer	0.000108	0.00159	CbGpPWpGaD
Bromazepam—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	0.000106	0.00156	CbGpPWpGaD
Bromazepam—Depressed level of consciousness—Methotrexate—bone cancer	0.000105	0.0155	CcSEcCtD
Bromazepam—GABRA6—Neuronal System—BRAF—bone cancer	0.000104	0.00152	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000103	0.00152	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—MDM2—bone cancer	0.000103	0.00151	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000103	0.00151	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—BRAF—bone cancer	0.000103	0.00151	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000102	0.0015	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—MDM2—bone cancer	9.96e-05	0.00146	CbGpPWpGaD
Bromazepam—Connective tissue disorder—Cisplatin—bone cancer	9.82e-05	0.0144	CcSEcCtD
Bromazepam—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	9.78e-05	0.00144	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—MDM2—bone cancer	9.78e-05	0.00144	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—MDM2—bone cancer	9.61e-05	0.00141	CbGpPWpGaD
Bromazepam—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	9.59e-05	0.00141	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—MDM2—bone cancer	9.55e-05	0.0014	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—MDM2—bone cancer	9.38e-05	0.00138	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—BRAF—bone cancer	9.38e-05	0.00138	CbGpPWpGaD
Bromazepam—Eye disorder—Cisplatin—bone cancer	9.34e-05	0.0137	CcSEcCtD
Bromazepam—GABRG3—Neuronal System—MDM2—bone cancer	9.34e-05	0.00137	CbGpPWpGaD
Bromazepam—Cardiac disorder—Cisplatin—bone cancer	9.28e-05	0.0136	CcSEcCtD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	9.25e-05	0.00136	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—MDM2—bone cancer	9.2e-05	0.00135	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—BRAF—bone cancer	9.11e-05	0.00134	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—BRAF—bone cancer	8.95e-05	0.00131	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.85e-05	0.0013	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—BRAF—bone cancer	8.79e-05	0.00129	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—BRAF—bone cancer	8.73e-05	0.00128	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.72e-05	0.00128	CbGpPWpGaD
Bromazepam—Malnutrition—Cisplatin—bone cancer	8.7e-05	0.0128	CcSEcCtD
Bromazepam—GABRA6—Neuronal System—MDM2—bone cancer	8.7e-05	0.00128	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	8.69e-05	0.00128	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—MDM2—bone cancer	8.59e-05	0.00126	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—BRAF—bone cancer	8.58e-05	0.00126	CbGpPWpGaD
Bromazepam—Muscle spasms—Cisplatin—bone cancer	8.37e-05	0.0123	CcSEcCtD
Bromazepam—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.21e-05	0.00121	CbGpPWpGaD
Bromazepam—Vision blurred—Cisplatin—bone cancer	8.2e-05	0.0121	CcSEcCtD
Bromazepam—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	8.2e-05	0.0012	CbGpPWpGaD
Bromazepam—Tremor—Cisplatin—bone cancer	8.15e-05	0.012	CcSEcCtD
Bromazepam—CYP1A2—Biological oxidations—CYP3A4—bone cancer	8.06e-05	0.00118	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—NDUFA12—bone cancer	8.03e-05	0.00118	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	7.95e-05	0.00117	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—MDM2—bone cancer	7.86e-05	0.00115	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—MDM2—bone cancer	7.63e-05	0.00112	CbGpPWpGaD
Bromazepam—Cardiac failure—Epirubicin—bone cancer	7.6e-05	0.0112	CcSEcCtD
Bromazepam—Irritability—Methotrexate—bone cancer	7.57e-05	0.0111	CcSEcCtD
Bromazepam—Convulsion—Cisplatin—bone cancer	7.54e-05	0.0111	CcSEcCtD
Bromazepam—GABRA1—Neuronal System—BRAF—bone cancer	7.5e-05	0.0011	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—MDM2—bone cancer	7.5e-05	0.0011	CbGpPWpGaD
Bromazepam—Ataxia—Methotrexate—bone cancer	7.46e-05	0.011	CcSEcCtD
Bromazepam—Diplopia—Epirubicin—bone cancer	7.42e-05	0.0109	CcSEcCtD
Bromazepam—GABRA2—Neuronal System—MDM2—bone cancer	7.37e-05	0.00108	CbGpPWpGaD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	7.36e-05	0.0108	CcSEcCtD
Bromazepam—GABRB3—Neuronal System—MDM2—bone cancer	7.32e-05	0.00107	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	7.27e-05	0.00107	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	7.27e-05	0.00107	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MDM2—bone cancer	7.19e-05	0.00106	CbGpPWpGaD
Bromazepam—Anaphylactic shock—Cisplatin—bone cancer	7.1e-05	0.0104	CcSEcCtD
Bromazepam—Cardiac arrest—Epirubicin—bone cancer	7.06e-05	0.0104	CcSEcCtD
Bromazepam—Cardiac failure—Doxorubicin—bone cancer	7.04e-05	0.0103	CcSEcCtD
Bromazepam—Ataxia—Epirubicin—bone cancer	6.98e-05	0.0103	CcSEcCtD
Bromazepam—Nervous system disorder—Cisplatin—bone cancer	6.97e-05	0.0102	CcSEcCtD
Bromazepam—Tachycardia—Cisplatin—bone cancer	6.93e-05	0.0102	CcSEcCtD
Bromazepam—Skin disorder—Cisplatin—bone cancer	6.9e-05	0.0101	CcSEcCtD
Bromazepam—CYP1A2—Biological oxidations—GSTP1—bone cancer	6.89e-05	0.00101	CbGpPWpGaD
Bromazepam—Diplopia—Doxorubicin—bone cancer	6.87e-05	0.0101	CcSEcCtD
Bromazepam—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	6.8e-05	0.000998	CbGpPWpGaD
Bromazepam—Anorexia—Cisplatin—bone cancer	6.77e-05	0.00995	CcSEcCtD
Bromazepam—CYP2E1—Metabolism—NT5C3A—bone cancer	6.66e-05	0.000978	CbGpPWpGaD
Bromazepam—Hypotension—Cisplatin—bone cancer	6.64e-05	0.00976	CcSEcCtD
Bromazepam—Muscular weakness—Epirubicin—bone cancer	6.55e-05	0.00962	CcSEcCtD
Bromazepam—Cardiac arrest—Doxorubicin—bone cancer	6.53e-05	0.0096	CcSEcCtD
Bromazepam—Ataxia—Doxorubicin—bone cancer	6.46e-05	0.00949	CcSEcCtD
Bromazepam—GABRA1—Neuronal System—MDM2—bone cancer	6.28e-05	0.000922	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—NDUFA12—bone cancer	6.2e-05	0.00091	CbGpPWpGaD
Bromazepam—Decreased appetite—Cisplatin—bone cancer	6.17e-05	0.00908	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Cisplatin—bone cancer	6.13e-05	0.00901	CcSEcCtD
Bromazepam—Drowsiness—Methotrexate—bone cancer	6.11e-05	0.00898	CcSEcCtD
Bromazepam—Muscular weakness—Doxorubicin—bone cancer	6.06e-05	0.0089	CcSEcCtD
Bromazepam—Feeling abnormal—Cisplatin—bone cancer	5.85e-05	0.0086	CcSEcCtD
Bromazepam—Drowsiness—Epirubicin—bone cancer	5.72e-05	0.00841	CcSEcCtD
Bromazepam—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.32e-05	0.000781	CbGpPWpGaD
Bromazepam—Drowsiness—Doxorubicin—bone cancer	5.29e-05	0.00778	CcSEcCtD
Bromazepam—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.25e-05	0.00077	CbGpPWpGaD
Bromazepam—Hypersensitivity—Cisplatin—bone cancer	5.23e-05	0.00769	CcSEcCtD
Bromazepam—CYP2C19—Metabolism—NT5C3A—bone cancer	5.14e-05	0.000754	CbGpPWpGaD
Bromazepam—Eye disorder—Methotrexate—bone cancer	5.13e-05	0.00754	CcSEcCtD
Bromazepam—Asthenia—Cisplatin—bone cancer	5.1e-05	0.00749	CcSEcCtD
Bromazepam—Cardiac disorder—Methotrexate—bone cancer	5.09e-05	0.00748	CcSEcCtD
Bromazepam—Connective tissue disorder—Epirubicin—bone cancer	5.05e-05	0.00742	CcSEcCtD
Bromazepam—CYP1A2—Metabolism—NDUFA12—bone cancer	4.83e-05	0.000709	CbGpPWpGaD
Bromazepam—Mental disorder—Methotrexate—bone cancer	4.81e-05	0.00707	CcSEcCtD
Bromazepam—Eye disorder—Epirubicin—bone cancer	4.8e-05	0.00705	CcSEcCtD
Bromazepam—Malnutrition—Methotrexate—bone cancer	4.78e-05	0.00702	CcSEcCtD
Bromazepam—Cardiac disorder—Epirubicin—bone cancer	4.77e-05	0.007	CcSEcCtD
Bromazepam—Connective tissue disorder—Doxorubicin—bone cancer	4.67e-05	0.00686	CcSEcCtD
Bromazepam—Vomiting—Cisplatin—bone cancer	4.52e-05	0.00664	CcSEcCtD
Bromazepam—Vision blurred—Methotrexate—bone cancer	4.5e-05	0.00662	CcSEcCtD
Bromazepam—Mental disorder—Epirubicin—bone cancer	4.5e-05	0.00661	CcSEcCtD
Bromazepam—Rash—Cisplatin—bone cancer	4.48e-05	0.00658	CcSEcCtD
Bromazepam—Dermatitis—Cisplatin—bone cancer	4.47e-05	0.00658	CcSEcCtD
Bromazepam—Malnutrition—Epirubicin—bone cancer	4.47e-05	0.00657	CcSEcCtD
Bromazepam—Eye disorder—Doxorubicin—bone cancer	4.44e-05	0.00653	CcSEcCtD
Bromazepam—Cardiac disorder—Doxorubicin—bone cancer	4.41e-05	0.00648	CcSEcCtD
Bromazepam—Tension—Epirubicin—bone cancer	4.39e-05	0.00645	CcSEcCtD
Bromazepam—Nervousness—Epirubicin—bone cancer	4.34e-05	0.00638	CcSEcCtD
Bromazepam—Muscle spasms—Epirubicin—bone cancer	4.3e-05	0.00632	CcSEcCtD
Bromazepam—Nausea—Cisplatin—bone cancer	4.22e-05	0.0062	CcSEcCtD
Bromazepam—Vision blurred—Epirubicin—bone cancer	4.21e-05	0.00619	CcSEcCtD
Bromazepam—Mental disorder—Doxorubicin—bone cancer	4.16e-05	0.00612	CcSEcCtD
Bromazepam—Convulsion—Methotrexate—bone cancer	4.14e-05	0.00608	CcSEcCtD
Bromazepam—Malnutrition—Doxorubicin—bone cancer	4.14e-05	0.00608	CcSEcCtD
Bromazepam—Agitation—Epirubicin—bone cancer	4.11e-05	0.00604	CcSEcCtD
Bromazepam—Tension—Doxorubicin—bone cancer	4.06e-05	0.00597	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	4.04e-05	0.00594	CcSEcCtD
Bromazepam—Nervousness—Doxorubicin—bone cancer	4.02e-05	0.0059	CcSEcCtD
Bromazepam—CYP1A2—Metabolism—NT5C3A—bone cancer	4e-05	0.000588	CbGpPWpGaD
Bromazepam—Muscle spasms—Doxorubicin—bone cancer	3.98e-05	0.00584	CcSEcCtD
Bromazepam—Palpitations—Epirubicin—bone cancer	3.95e-05	0.00581	CcSEcCtD
Bromazepam—Confusional state—Methotrexate—bone cancer	3.93e-05	0.00578	CcSEcCtD
Bromazepam—Anaphylactic shock—Methotrexate—bone cancer	3.9e-05	0.00573	CcSEcCtD
Bromazepam—Vision blurred—Doxorubicin—bone cancer	3.9e-05	0.00573	CcSEcCtD
Bromazepam—Convulsion—Epirubicin—bone cancer	3.87e-05	0.00569	CcSEcCtD
Bromazepam—Nervous system disorder—Methotrexate—bone cancer	3.82e-05	0.00562	CcSEcCtD
Bromazepam—Agitation—Doxorubicin—bone cancer	3.8e-05	0.00559	CcSEcCtD
Bromazepam—Skin disorder—Methotrexate—bone cancer	3.79e-05	0.00557	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	3.78e-05	0.00555	CcSEcCtD
Bromazepam—CYP3A4—Metabolism—NDUFA12—bone cancer	3.73e-05	0.000547	CbGpPWpGaD
Bromazepam—Dry mouth—Epirubicin—bone cancer	3.72e-05	0.00547	CcSEcCtD
Bromazepam—Anorexia—Methotrexate—bone cancer	3.72e-05	0.00546	CcSEcCtD
Bromazepam—Confusional state—Epirubicin—bone cancer	3.68e-05	0.00541	CcSEcCtD
Bromazepam—Palpitations—Doxorubicin—bone cancer	3.65e-05	0.00537	CcSEcCtD
Bromazepam—Anaphylactic shock—Epirubicin—bone cancer	3.65e-05	0.00536	CcSEcCtD
Bromazepam—Hypotension—Methotrexate—bone cancer	3.64e-05	0.00535	CcSEcCtD
Bromazepam—Convulsion—Doxorubicin—bone cancer	3.58e-05	0.00527	CcSEcCtD
Bromazepam—Nervous system disorder—Epirubicin—bone cancer	3.58e-05	0.00526	CcSEcCtD
Bromazepam—Tachycardia—Epirubicin—bone cancer	3.56e-05	0.00523	CcSEcCtD
Bromazepam—Skin disorder—Epirubicin—bone cancer	3.54e-05	0.00521	CcSEcCtD
Bromazepam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	3.5e-05	0.00514	CcSEcCtD
Bromazepam—Anorexia—Epirubicin—bone cancer	3.48e-05	0.00511	CcSEcCtD
Bromazepam—Somnolence—Methotrexate—bone cancer	3.47e-05	0.00509	CcSEcCtD
Bromazepam—Dry mouth—Doxorubicin—bone cancer	3.44e-05	0.00506	CcSEcCtD
Bromazepam—Dyspepsia—Methotrexate—bone cancer	3.43e-05	0.00504	CcSEcCtD
Bromazepam—Hypotension—Epirubicin—bone cancer	3.41e-05	0.00501	CcSEcCtD
Bromazepam—Confusional state—Doxorubicin—bone cancer	3.4e-05	0.005	CcSEcCtD
Bromazepam—Decreased appetite—Methotrexate—bone cancer	3.39e-05	0.00498	CcSEcCtD
Bromazepam—Anaphylactic shock—Doxorubicin—bone cancer	3.38e-05	0.00496	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Methotrexate—bone cancer	3.37e-05	0.00495	CcSEcCtD
Bromazepam—Fatigue—Methotrexate—bone cancer	3.36e-05	0.00494	CcSEcCtD
Bromazepam—Nervous system disorder—Doxorubicin—bone cancer	3.31e-05	0.00487	CcSEcCtD
Bromazepam—Tachycardia—Doxorubicin—bone cancer	3.29e-05	0.00484	CcSEcCtD
Bromazepam—Skin disorder—Doxorubicin—bone cancer	3.28e-05	0.00482	CcSEcCtD
Bromazepam—Somnolence—Epirubicin—bone cancer	3.24e-05	0.00477	CcSEcCtD
Bromazepam—Anorexia—Doxorubicin—bone cancer	3.22e-05	0.00473	CcSEcCtD
Bromazepam—Feeling abnormal—Methotrexate—bone cancer	3.21e-05	0.00472	CcSEcCtD
Bromazepam—Dyspepsia—Epirubicin—bone cancer	3.21e-05	0.00472	CcSEcCtD
Bromazepam—Decreased appetite—Epirubicin—bone cancer	3.17e-05	0.00466	CcSEcCtD
Bromazepam—Hypotension—Doxorubicin—bone cancer	3.15e-05	0.00464	CcSEcCtD
Bromazepam—Gastrointestinal disorder—Epirubicin—bone cancer	3.15e-05	0.00463	CcSEcCtD
Bromazepam—Fatigue—Epirubicin—bone cancer	3.14e-05	0.00462	CcSEcCtD
Bromazepam—CYP3A4—Metabolism—NT5C3A—bone cancer	3.09e-05	0.000454	CbGpPWpGaD
Bromazepam—Feeling abnormal—Epirubicin—bone cancer	3.01e-05	0.00442	CcSEcCtD
Bromazepam—Somnolence—Doxorubicin—bone cancer	3e-05	0.00441	CcSEcCtD
Bromazepam—Dyspepsia—Doxorubicin—bone cancer	2.97e-05	0.00437	CcSEcCtD
Bromazepam—Decreased appetite—Doxorubicin—bone cancer	2.93e-05	0.00431	CcSEcCtD
Bromazepam—CYP2E1—Metabolism—ENO2—bone cancer	2.92e-05	0.000428	CbGpPWpGaD
Bromazepam—Gastrointestinal disorder—Doxorubicin—bone cancer	2.91e-05	0.00428	CcSEcCtD
Bromazepam—Fatigue—Doxorubicin—bone cancer	2.91e-05	0.00428	CcSEcCtD
Bromazepam—Hypersensitivity—Methotrexate—bone cancer	2.87e-05	0.00422	CcSEcCtD
Bromazepam—Asthenia—Methotrexate—bone cancer	2.8e-05	0.00411	CcSEcCtD
Bromazepam—Feeling abnormal—Doxorubicin—bone cancer	2.78e-05	0.00409	CcSEcCtD
Bromazepam—Pruritus—Methotrexate—bone cancer	2.76e-05	0.00405	CcSEcCtD
Bromazepam—CYP2E1—Metabolism—DHFR—bone cancer	2.71e-05	0.000397	CbGpPWpGaD
Bromazepam—Hypersensitivity—Epirubicin—bone cancer	2.69e-05	0.00395	CcSEcCtD
Bromazepam—Asthenia—Epirubicin—bone cancer	2.62e-05	0.00385	CcSEcCtD
Bromazepam—Pruritus—Epirubicin—bone cancer	2.58e-05	0.00379	CcSEcCtD
Bromazepam—Dizziness—Methotrexate—bone cancer	2.58e-05	0.00379	CcSEcCtD
Bromazepam—CYP2E1—Metabolism—GNA11—bone cancer	2.53e-05	0.000371	CbGpPWpGaD
Bromazepam—Hypersensitivity—Doxorubicin—bone cancer	2.49e-05	0.00366	CcSEcCtD
Bromazepam—Vomiting—Methotrexate—bone cancer	2.48e-05	0.00364	CcSEcCtD
Bromazepam—Rash—Methotrexate—bone cancer	2.46e-05	0.00361	CcSEcCtD
Bromazepam—Dermatitis—Methotrexate—bone cancer	2.46e-05	0.00361	CcSEcCtD
Bromazepam—Headache—Methotrexate—bone cancer	2.44e-05	0.00359	CcSEcCtD
Bromazepam—Asthenia—Doxorubicin—bone cancer	2.42e-05	0.00356	CcSEcCtD
Bromazepam—Dizziness—Epirubicin—bone cancer	2.41e-05	0.00355	CcSEcCtD
Bromazepam—Pruritus—Doxorubicin—bone cancer	2.39e-05	0.00351	CcSEcCtD
Bromazepam—Vomiting—Epirubicin—bone cancer	2.32e-05	0.00341	CcSEcCtD
Bromazepam—Nausea—Methotrexate—bone cancer	2.32e-05	0.0034	CcSEcCtD
Bromazepam—Rash—Epirubicin—bone cancer	2.3e-05	0.00338	CcSEcCtD
Bromazepam—Dermatitis—Epirubicin—bone cancer	2.3e-05	0.00338	CcSEcCtD
Bromazepam—CYP2E1—Metabolism—CYP3A4—bone cancer	2.29e-05	0.000337	CbGpPWpGaD
Bromazepam—Headache—Epirubicin—bone cancer	2.29e-05	0.00336	CcSEcCtD
Bromazepam—CYP2C19—Metabolism—ENO2—bone cancer	2.25e-05	0.00033	CbGpPWpGaD
Bromazepam—Dizziness—Doxorubicin—bone cancer	2.23e-05	0.00328	CcSEcCtD
Bromazepam—Nausea—Epirubicin—bone cancer	2.17e-05	0.00318	CcSEcCtD
Bromazepam—Vomiting—Doxorubicin—bone cancer	2.15e-05	0.00315	CcSEcCtD
Bromazepam—Rash—Doxorubicin—bone cancer	2.13e-05	0.00313	CcSEcCtD
Bromazepam—Dermatitis—Doxorubicin—bone cancer	2.13e-05	0.00313	CcSEcCtD
Bromazepam—Headache—Doxorubicin—bone cancer	2.11e-05	0.00311	CcSEcCtD
Bromazepam—CYP2C19—Metabolism—DHFR—bone cancer	2.09e-05	0.000306	CbGpPWpGaD
Bromazepam—Nausea—Doxorubicin—bone cancer	2e-05	0.00295	CcSEcCtD
Bromazepam—CYP2E1—Metabolism—GSTP1—bone cancer	1.96e-05	0.000288	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GNA11—bone cancer	1.95e-05	0.000286	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CYP3A4—bone cancer	1.77e-05	0.00026	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.76e-05	0.000258	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ENO2—bone cancer	1.75e-05	0.000257	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—DHFR—bone cancer	1.63e-05	0.000239	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GNA11—bone cancer	1.52e-05	0.000223	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GSTP1—bone cancer	1.51e-05	0.000222	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CYP3A4—bone cancer	1.38e-05	0.000202	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.37e-05	0.000201	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ENO2—bone cancer	1.35e-05	0.000199	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—DHFR—bone cancer	1.26e-05	0.000184	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GSTP1—bone cancer	1.18e-05	0.000173	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GNA11—bone cancer	1.17e-05	0.000172	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—PTGS2—bone cancer	1.02e-05	0.000149	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GSTP1—bone cancer	9.1e-06	0.000134	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—PTGS2—bone cancer	7.84e-06	0.000115	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—PTGS2—bone cancer	6.11e-06	8.97e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—PTGS2—bone cancer	4.71e-06	6.92e-05	CbGpPWpGaD
